Antibody data
- Antibody Data
- Antigen structure
- References [97]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 23306-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#23306-1-AP, RRID:AB_2721185
- Product name
- WWTR1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated WWTR1 antibody (Cat. #23306-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references FAM188B promotes progression of hepatocellular carcinoma by regulating YAP/TAZ via interaction with USP10.
TEAD1 Enhances Exosome Secretion and Promotes Exosome-Mediated Tissue Regeneration.
Identification of Nitric Oxide-Donating Lenumlostat Derivatives with Dual Activities of Extracellular Matrix Dysregulation Inhibition and Pulmonary Vasodilation for the Treatment of Pulmonary Arterial Hypertension.
Jianpi Jiedu Xiaozheng Fang Regulates Hepatocellular Carcinoma Proliferation and Metastasis Based on Network Pharmacology.
Matrix stiffness promotes corneal fibrosis through the YAP/TAZ-β-catenin mechanotransduction pathway: Proteomic and functional validation.
TAZ alleviates ischemic stroke injury by activating Foxo1: Usp1-mediated deubiquitination is the pivotal mechanism.
HSPA5 promotes YAP/TAZ stability independently of the Hippo pathway and induces proneural-to-mesenchymal transition in glioblastoma.
Trimethylamine-N-oxide disrupts spermatogenesis by inducing mitochondrial oxidative stress injury through Hippo signaling.
Application of Intracellular Vesicles Surpass Extracellular Vesicles in Regenerative Repair of Inflammatory Bone Defects via the LAMA4-Mediated YAP/TAZ Signalling.
Neu-P11 Improves Type 2 Diabetes Mellitus Immune Function by Inhibiting the Hippo Signaling Pathway.
Notch-Driven Cholangiocarcinogenesis Involves the Hippo Pathway Effector TAZ via METTL3-m6A-YTHDF1.
Xuebijing Injection Alleviates Sepsis-Induced Acute Lung Injury by Inhibition of Cell Apoptosis and Inflammation Through the Hippo Pathway.
RHOBTB2 enhances cell proliferation of acute myeloid leukemia by modulating Hippo-YAP1 signaling and dependent of KLHL13.
MicroRNA-29a attenuates inflammation and fibrosis in an animal model of NASH through MCJ inhibition and hippo pathway regulation.
Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology.
MISP promotes the progression of lung adenocarcinoma through Inhibition of the Hippo signaling pathway.
CUDC-907 exerts an inhibitory effect on non-small cell lung cancer associated with induction of mitotic catastrophe and downregulation of YAP/TAZ signaling.
Low-Intensity Ultrasound Stimulates TAZ in Schwann cells.
Liraglutide improves senescence and ameliorating diabetic sarcopenia via the YAP-TAZ pathway.
YAP/TAZ-mediated nuclear membrane rupture in promoting senescence of skeletal muscle associated with COPD.
YAP maintains the dynamics of TDP-43 condensates and antagonizes TDP-43 pathological aggregates.
The cardiac glycoside periplocymarin sensitizes gastric cancer to ferroptosis via the ATP1A1-Src-YAP/TAZ-TFRC axis.
Discovery of 2-Pyrazolylpyrimidinone Derivatives as New SPOP Inhibitors for Renal Cell Carcinoma Therapy.
Dynamic decoding of VEGF signaling and coordinated control of multiple phenotypes by the Src-TEM4-YAP pathway.
The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ.
Cyclovirobuxine D inhibits triple-negative breast cancer via YAP/TAZ suppression and activation of the FOXO3a/PINK1-Parkin pathway-induced mitophagy.
CK2α-mediated phosphorylation of DUB3 promotes YAP1 stability and oncogenic functions.
Activation of PAR1 contributes to ferroptosis of Schwann cells and inhibits regeneration of myelin sheath after sciatic nerve crush injury in rats via Hippo-YAP/ACSL4 pathway.
6-Methoxydihydrosanguinarine Suppresses the Proliferation of Non-small Cell Lung Cancer Cells through Elevation of ROS and Activation of IRE1/JNK Signaling.
Design and Optimization of LOXL2 and sGC Dual-Target Regulators Targeting Extracellular Matrix Dysregulation and Vasodilation for the Treatment of Pulmonary Arterial Hypertension.
F2RL1 Inhibition Alleviates Lipotoxicity-Induced Kidney Injury Through the Hippo Pathway in Diabetic Kidney Disease.
CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathways.
Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth.
Mesenchymal-epithelial transition reduces proliferation but increases immune evasion in tumor spheroids.
Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48.
Silencing of fibronectin type III domain-containing protein 3A (FNDC3A) attenuates epithelial-to-mesenchymal transition (EMT), cancer invasion, and stemness in triple-negative breast cancer (TNBC).
CDK4/6-mediated phosphorylation of DUB3 promotes YAP1 stability and hepatocellular carcinoma progression.
TAZ/NRF2 positive feedback loop contributes to proliferation in bladder cancer through antagonistic ferroptosis.
Inhibition of Rho GEFs attenuates pulmonary fibrosis through suppressing myofibroblast activation and reprogramming profibrotic macrophages.
FATP5 modulates biological activity and lipid metabolism in prostate cancer through the TEAD4-mediated Hippo signaling.
CircHIPK2 Contributes Cell Growth in Intestinal Epithelial of Colitis and Colorectal Cancer through Promoting TAZ Translation.
Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo.
A TBK1-independent primordial function of STING in lysosomal biogenesis.
Angiotensin II depends on hippo/YAP signaling to reprogram angiogenesis and promote liver fibrosis.
Ischemia-inhibited ferric chelate reductase 1 improves ferroptosis-mediated intestinal ischemia injury via Hippo signaling.
NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization.
LncRNA-SNHG5 mediates activation of hepatic stellate cells by regulating NF2 and Hippo pathway.
Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
Abnormal mechanical stress induced chondrocyte senescence by YAP loss-mediated METTL3 upregulation.
YAP and TAZ regulate remyelination in the central nervous system.
Activating transcriptional coactivator with PDZ-binding motif by (R)-PFI-2 attenuates osteoclastogenesis and prevents ovariectomized-induced osteoporosis.
Mic19 depletion impairs endoplasmic reticulum-mitochondrial contacts and mitochondrial lipid metabolism and triggers liver disease.
TGFβ and Hippo Signaling Pathways Coordinate to Promote Acinar to Ductal Metaplasia in Human Pancreas.
Transcriptomics analysis revealed that TAZ regulates the proliferation of KIRC cells through mitophagy.
Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial Hypertension.
DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis.
LncRNA PVT1 promotes strong stemness and endothelial progenitor cell characteristics in renal carcinoma stem cells.
Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Targeting endothelial coagulation signaling ameliorates liver obstructive cholestasis and dysfunctional angiogenesis.
PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling.
USP15 promotes pulmonary vascular remodeling in pulmonary hypertension in a YAP1/TAZ-dependent manner.
TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.
Proteomic analysis reveals the aging-related pathways contribute to pulmonary fibrogenesis.
Lipid-Sensing Receptor FFAR4 Modulates Pulmonary Epithelial Homeostasis following Immunogenic Exposures Independently of the FFAR4 Ligand Docosahexaenoic Acid (DHA).
The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer.
A positive feedback loop of the TAZ/β-catenin axis promotes Helicobacter pylori-associated gastric carcinogenesis.
Mesenchymal Stem Cells Inhibits Migration and Vasculogenic Mimicry in Nasopharyngeal Carcinoma Via Exosomal MiR-125a.
Ring finger protein 128 promotes, rather than inhibits, colorectal cancer progression by regulating the Hippo signaling pathway.
Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and ameliorates organ fibrosis.
PSMA1 mediates tumor progression and poor prognosis of gastric carcinoma by deubiquitinating and stabilizing TAZ.
WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells.
The proteasome-dependent degradation of ALKBH5 regulates ECM deposition in PM(2.5) exposure-induced pulmonary fibrosis of mice.
DEPTOR exacerbates bone-fat imbalance in osteoporosis by transcriptionally modulating BMSC differentiation.
Piezo channels contribute to the regulation of myelination in Schwann cells.
Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway.
USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ.
Traditional Chinese medicine Yiqi Huoxue recipe attenuates hepatic fibrosis via YAP/TAZ signaling.
YAP drives fate conversion and chemoresistance of small cell lung cancer.
CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling.
Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty liver disease by regulating the YAP1/TAZ-PPARγ/PGC-1α signaling pathway.
The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ.
YAP and TAZ regulate Schwann cell proliferation and differentiation during peripheral nerve regeneration.
The lncRNA BCYRN1 Functions as an Oncogene in Human Glioma by Downregulating miR-125a-5p in vitro.
MiR-34a-5p Inhibits Proliferation, Migration, Invasion and Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma by Targeting LEF1 and Inactivation of the Hippo-YAP1/TAZ Signaling Pathway.
YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.
A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.
Vitamin D3 analogue facilitates epithelial wound healing through promoting epithelial-mesenchymal transition via the Hippo pathway.
TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.
Jiedu Sangen Decoction Inhibits the Invasion and Metastasis of Colorectal Cancer Cells by Regulating EMT through the Hippo Signaling Pathway.
miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ.
MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance.
MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer.
Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.
YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells.
Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.
Hu S, Wen Y, Chen Y, Fang Y, Mu M, Tu L, Chen W, Tu K, Liu X, Xu Q, Huang D, Li X
Journal of Cancer 2026;17(3):626-636
Journal of Cancer 2026;17(3):626-636
TEAD1 Enhances Exosome Secretion and Promotes Exosome-Mediated Tissue Regeneration.
Pu Y, Wan Y, Shi W, Li B, Zhang H, Wu J, Li L, Guo W, Ding C, Yang W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 May;13(25):e14104
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 May;13(25):e14104
Identification of Nitric Oxide-Donating Lenumlostat Derivatives with Dual Activities of Extracellular Matrix Dysregulation Inhibition and Pulmonary Vasodilation for the Treatment of Pulmonary Arterial Hypertension.
Hu Y, Wang Y, Tan W, Zhao C, Li M, Xiang S, Liang X, Gao R, Zeng B, Chen Z, Hu L, Li Q
Journal of medicinal chemistry 2026 May 14;69(9):11448-11470
Journal of medicinal chemistry 2026 May 14;69(9):11448-11470
Jianpi Jiedu Xiaozheng Fang Regulates Hepatocellular Carcinoma Proliferation and Metastasis Based on Network Pharmacology.
Li B, Shi HQ, Luo R, Zhang ZQ, Dong XC, Li XH, Ye SQ, Zhong C
Journal of cellular and molecular medicine 2026 Mar;30(5):e71040
Journal of cellular and molecular medicine 2026 Mar;30(5):e71040
Matrix stiffness promotes corneal fibrosis through the YAP/TAZ-β-catenin mechanotransduction pathway: Proteomic and functional validation.
Li K, Fu H, Miao L, Lu Y, He C, Liu Y, Hu Z, Xie B, Lv X, Lu F, Lin M, Hu L
Acta biomaterialia 2026 Jun;216:215-233
Acta biomaterialia 2026 Jun;216:215-233
TAZ alleviates ischemic stroke injury by activating Foxo1: Usp1-mediated deubiquitination is the pivotal mechanism.
Xin Y, Sun Y, Pan E, Li M, Chen H, Xu Y, Zhang B, Shi Y, Dong J, Zhao P
Free radical biology & medicine 2026 Jul;250:548-563
Free radical biology & medicine 2026 Jul;250:548-563
HSPA5 promotes YAP/TAZ stability independently of the Hippo pathway and induces proneural-to-mesenchymal transition in glioblastoma.
Gui S, Yu W, Song Z, Peng L, Luo H, Huang K, Xiao J, Xie J, Cai S, Yuan S, Tao Z, Cheng Z
Cell death & disease 2026 Feb 7;17(1):208
Cell death & disease 2026 Feb 7;17(1):208
Trimethylamine-N-oxide disrupts spermatogenesis by inducing mitochondrial oxidative stress injury through Hippo signaling.
Wang S, Ma G, Qi C, Cheng S, Lai H, Zhou L, Wu G, Chen Z, Mao X, Jing T, He Y, Zhou H
Free radical biology & medicine 2026 Feb 1;243:452-465
Free radical biology & medicine 2026 Feb 1;243:452-465
Application of Intracellular Vesicles Surpass Extracellular Vesicles in Regenerative Repair of Inflammatory Bone Defects via the LAMA4-Mediated YAP/TAZ Signalling.
Liu H, Wu Y, Wang Q, Zhang T, Tong X, Yan F, Zhang Q
Journal of extracellular vesicles 2026 Apr;15(4):e70267
Journal of extracellular vesicles 2026 Apr;15(4):e70267
Neu-P11 Improves Type 2 Diabetes Mellitus Immune Function by Inhibiting the Hippo Signaling Pathway.
Cai S, Qi SK, Mao LN, Xie L, He J, Li YZ, Li XP
International journal of endocrinology 2025;2025:3385546
International journal of endocrinology 2025;2025:3385546
Notch-Driven Cholangiocarcinogenesis Involves the Hippo Pathway Effector TAZ via METTL3-m6A-YTHDF1.
Ma W, Zhang J, Chen W, Liu N, Wu T
Cellular and molecular gastroenterology and hepatology 2025;19(1):101417
Cellular and molecular gastroenterology and hepatology 2025;19(1):101417
Xuebijing Injection Alleviates Sepsis-Induced Acute Lung Injury by Inhibition of Cell Apoptosis and Inflammation Through the Hippo Pathway.
Ling B, Ji J, Huang Q, Xu Y, Hu Y, Pan S, Liu S, Hua T, Tang L, Yang M
Journal of inflammation research 2025;18:7717-7733
Journal of inflammation research 2025;18:7717-7733
RHOBTB2 enhances cell proliferation of acute myeloid leukemia by modulating Hippo-YAP1 signaling and dependent of KLHL13.
Liu Y, Zhou F, Wang L, Xue Y, Wang W
Scientific reports 2025 Oct 17;15(1):36428
Scientific reports 2025 Oct 17;15(1):36428
MicroRNA-29a attenuates inflammation and fibrosis in an animal model of NASH through MCJ inhibition and hippo pathway regulation.
Yang YL, Huang YH
European journal of pharmacology 2025 Oct 15;1005:178107
European journal of pharmacology 2025 Oct 15;1005:178107
Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology.
Huo C, Li F, Guo L, Sun X, Guo Y, Chen X, Liu K, Wang C, Zhang C, Zhang W, Li J, Yang Y, Wang H, Zou X, Ma X, Zhai C
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Nov 25;148:157480
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Nov 25;148:157480
MISP promotes the progression of lung adenocarcinoma through Inhibition of the Hippo signaling pathway.
Cheng Y, Shen Y, Fang W, Duan S, Wang Y, Dai X, Chen Y
Discover oncology 2025 Nov 17;16(1):2116
Discover oncology 2025 Nov 17;16(1):2116
CUDC-907 exerts an inhibitory effect on non-small cell lung cancer associated with induction of mitotic catastrophe and downregulation of YAP/TAZ signaling.
Liu Y, Qi X, Luo XP, Wang YF, Wan JJ, Wang FZ, Zhang WY
Chemico-biological interactions 2025 Nov 1;421:111735
Chemico-biological interactions 2025 Nov 1;421:111735
Low-Intensity Ultrasound Stimulates TAZ in Schwann cells.
Acheta J, Jeanette H, Mondschein AS, Lanka M, Belin S, Poitelon Y
bioRxiv : the preprint server for biology 2025 May 14;
bioRxiv : the preprint server for biology 2025 May 14;
Liraglutide improves senescence and ameliorating diabetic sarcopenia via the YAP-TAZ pathway.
Xu Q, Qiu X, Di H, Li Z, Liu Z, Liu K
Journal of diabetes and its complications 2025 Mar;39(3):108975
Journal of diabetes and its complications 2025 Mar;39(3):108975
YAP/TAZ-mediated nuclear membrane rupture in promoting senescence of skeletal muscle associated with COPD.
Gong G, Shen S, Shen S, Wang R, Zheng T, Xu W, Wu J
Respiratory research 2025 Mar 12;26(1):98
Respiratory research 2025 Mar 12;26(1):98
YAP maintains the dynamics of TDP-43 condensates and antagonizes TDP-43 pathological aggregates.
Zhang J, Hu J, Liu R, Zhou T, Luo X, Liang P, Xie Z, Zhao Q, Chen Y, Du D, Liu C, Zheng Y, Li D, Wang B
Nature cell biology 2025 Jul;27(7):1148-1160
Nature cell biology 2025 Jul;27(7):1148-1160
The cardiac glycoside periplocymarin sensitizes gastric cancer to ferroptosis via the ATP1A1-Src-YAP/TAZ-TFRC axis.
Ke A, Yang W, Zhang W, Chen Y, Meng X, Liu J, Dai D
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Jul;142:156804
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Jul;142:156804
Discovery of 2-Pyrazolylpyrimidinone Derivatives as New SPOP Inhibitors for Renal Cell Carcinoma Therapy.
Zhang Q, Zhou Y, Zhao J, Hu L, Zhu Z, Wang H, Jin Y, You Q, Jiang Z, Guo X
Journal of medicinal chemistry 2025 Jul 24;68(14):14945-14961
Journal of medicinal chemistry 2025 Jul 24;68(14):14945-14961
Dynamic decoding of VEGF signaling and coordinated control of multiple phenotypes by the Src-TEM4-YAP pathway.
Lee SH, Kang TY, Shang X, Levchenko A
Cell systems 2025 Jul 16;16(7):101321
Cell systems 2025 Jul 16;16(7):101321
The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ.
Peng Y, Nie H, Kang K, Li X, Tao Y, Zhou Y
Cancer gene therapy 2025 Jan;32(1):136-145
Cancer gene therapy 2025 Jan;32(1):136-145
Cyclovirobuxine D inhibits triple-negative breast cancer via YAP/TAZ suppression and activation of the FOXO3a/PINK1-Parkin pathway-induced mitophagy.
Wang ZQ, Wu ZX, Chen JW, Li HF, Wu HD, Bao JX, Cheng Y, Dai YW, Wang OC, Dai XX
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Jan;136:156287
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Jan;136:156287
CK2α-mediated phosphorylation of DUB3 promotes YAP1 stability and oncogenic functions.
Huang L, Wen Y, Guo Q, Zhang C, Yang X, Li M, Liu Y, Li X, Tang J, Zhou X, Qi Q, Zhang H, Liu T
Cell death & disease 2025 Jan 18;16(1):27
Cell death & disease 2025 Jan 18;16(1):27
Activation of PAR1 contributes to ferroptosis of Schwann cells and inhibits regeneration of myelin sheath after sciatic nerve crush injury in rats via Hippo-YAP/ACSL4 pathway.
Wu Z, Sun J, Liao Z, Sun T, Huang L, Qiao J, Ling C, Chen C, Zhang B, Wang H
Experimental neurology 2025 Feb;384:115053
Experimental neurology 2025 Feb;384:115053
6-Methoxydihydrosanguinarine Suppresses the Proliferation of Non-small Cell Lung Cancer Cells through Elevation of ROS and Activation of IRE1/JNK Signaling.
Qi X, Niu C, Zhang ZZ, Chen MR, Wang FZ, Fei HR
Cell biochemistry and biophysics 2025 Dec;83(4):5307-5319
Cell biochemistry and biophysics 2025 Dec;83(4):5307-5319
Design and Optimization of LOXL2 and sGC Dual-Target Regulators Targeting Extracellular Matrix Dysregulation and Vasodilation for the Treatment of Pulmonary Arterial Hypertension.
Hu Y, Wang Y, Tan W, Zhao C, Li M, Xiang S, Liang X, Gao R, Zeng B, Chen Z, Hu L, Li Q
Journal of medicinal chemistry 2025 Dec 25;68(24):26547-26573
Journal of medicinal chemistry 2025 Dec 25;68(24):26547-26573
F2RL1 Inhibition Alleviates Lipotoxicity-Induced Kidney Injury Through the Hippo Pathway in Diabetic Kidney Disease.
Wang H, Wang W, Jiang Y, Cui S, Kong Y, Chen YQ, Zhu S
Inflammation 2025 Aug;48(4):2628-2639
Inflammation 2025 Aug;48(4):2628-2639
CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathways.
He J, Zhang L, Xu H, Gao C, Zhao W, Zhang B, Han W, Zhao W, Tan G, Chen S, Zhong P, Shen Z, Meng J, Tang Z, Lu H, Gao X, Li Z, Li W, Mao J, Liu B, Zhang YW, Wang Z
Journal of experimental & clinical cancer research : CR 2025 Aug 5;44(1):228
Journal of experimental & clinical cancer research : CR 2025 Aug 5;44(1):228
Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth.
Zhao G, Luo S, Zhao H, Ma Q, Jiang H, Wang L, Liu J, Guo D, Wang R, Xu Q, Lun J, Xie R, Duan Y, Ma L, Qiu W, Fang J, Lu Z
Nature communications 2025 Aug 4;16(1):7156
Nature communications 2025 Aug 4;16(1):7156
Mesenchymal-epithelial transition reduces proliferation but increases immune evasion in tumor spheroids.
Dimari G, Hu Y, Frenzel A, Fuchs A, Wurm AA, Fischer-Friedrich E
iScience 2025 Aug 15;28(8):113023
iScience 2025 Aug 15;28(8):113023
Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48.
Xiao J, Liu J, Zhang C, Liu Z, Nie Z, Yi Z, Gao X, Liang H, Huang J, Cai Z, Yan L, Wu B, Liu Z, Chen J, Zu X, Hu J
Journal for immunotherapy of cancer 2025 Aug 11;13(8)
Journal for immunotherapy of cancer 2025 Aug 11;13(8)
Silencing of fibronectin type III domain-containing protein 3A (FNDC3A) attenuates epithelial-to-mesenchymal transition (EMT), cancer invasion, and stemness in triple-negative breast cancer (TNBC).
Wada N, Sakai S, Inoue Y, Nishizuka M
Biochimica et biophysica acta. Molecular cell research 2025 Apr;1872(4):119935
Biochimica et biophysica acta. Molecular cell research 2025 Apr;1872(4):119935
CDK4/6-mediated phosphorylation of DUB3 promotes YAP1 stability and hepatocellular carcinoma progression.
Huang L, Yuan W, Li X, Liu Y, Wan R, Ma X, Liu T, Liang J, Zhu Y
Cell death discovery 2025 Apr 30;11(1):212
Cell death discovery 2025 Apr 30;11(1):212
TAZ/NRF2 positive feedback loop contributes to proliferation in bladder cancer through antagonistic ferroptosis.
Song Z, Gui S, Rao X, Zhang G, Cheng Y, Zeng T
Cell death discovery 2025 Apr 29;11(1):208
Cell death discovery 2025 Apr 29;11(1):208
Inhibition of Rho GEFs attenuates pulmonary fibrosis through suppressing myofibroblast activation and reprogramming profibrotic macrophages.
Luo C, Huang C, Zhu Y, Zhou Y, Qiao Y, Shi C, Gao Y, Guo Y, Wei L
Cell death & disease 2025 Apr 11;16(1):278
Cell death & disease 2025 Apr 11;16(1):278
FATP5 modulates biological activity and lipid metabolism in prostate cancer through the TEAD4-mediated Hippo signaling.
Liu S, He Y, Gu Z
Frontiers in oncology 2024;14:1442911
Frontiers in oncology 2024;14:1442911
CircHIPK2 Contributes Cell Growth in Intestinal Epithelial of Colitis and Colorectal Cancer through Promoting TAZ Translation.
Zeng X, Tang J, Zhang Q, Wang C, Qi J, Wei Y, Xu J, Yang K, Zhou Z, Wu H, Luo J, Jiang Y, Song Z, Wu J, Wu J
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Sep;11(34):e2401588
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Sep;11(34):e2401588
Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo.
Yang X, Liu Z, Wang X, Tian W, Zhao T, Yang Q, Li W, Yang L, Yang H, Jia Y
Chemico-biological interactions 2024 Sep 1;400:111176
Chemico-biological interactions 2024 Sep 1;400:111176
A TBK1-independent primordial function of STING in lysosomal biogenesis.
Lv B, Dion WA, Yang H, Xun J, Kim DH, Zhu B, Tan JX
Molecular cell 2024 Oct 17;84(20):3979-3996.e9
Molecular cell 2024 Oct 17;84(20):3979-3996.e9
Angiotensin II depends on hippo/YAP signaling to reprogram angiogenesis and promote liver fibrosis.
Zhou Y, Liang P, Bi T, Tang B, Zhu X, Liu X, Wang H, Shen H, Sun Q, Yang S, Ren W
Cellular signalling 2024 Nov;123:111355
Cellular signalling 2024 Nov;123:111355
Ischemia-inhibited ferric chelate reductase 1 improves ferroptosis-mediated intestinal ischemia injury via Hippo signaling.
Liang P, Xie W, Wang X, Du Z, Zheng C, Zhao H, Wang Z, Ji Z
International immunopharmacology 2024 May 10;132:111900
International immunopharmacology 2024 May 10;132:111900
NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization.
Zou S, Huang Y, Yang Z, Zhang J, Meng M, Zhang Y, Feng J, Sun R, Li W, Wang W, López JG, Fang L
Clinical and translational medicine 2024 Mar;14(3):e1621
Clinical and translational medicine 2024 Mar;14(3):e1621
LncRNA-SNHG5 mediates activation of hepatic stellate cells by regulating NF2 and Hippo pathway.
Zhang R, Zhan Y, Lang Z, Li Y, Zhang W, Zheng J
Communications biology 2024 Mar 4;7(1):266
Communications biology 2024 Mar 4;7(1):266
Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
Guo C, Zhang M, Jin X, Zhu C, Qian J, Tao M
Cell biochemistry and function 2024 Jun;42(4):e4020
Cell biochemistry and function 2024 Jun;42(4):e4020
Abnormal mechanical stress induced chondrocyte senescence by YAP loss-mediated METTL3 upregulation.
Yang F, Wang P, Dong X, Dai W, Chen W, Yuan G, Bai D, Xu H
Oral diseases 2024 Jul;30(5):3308-3320
Oral diseases 2024 Jul;30(5):3308-3320
YAP and TAZ regulate remyelination in the central nervous system.
Hong J, Kirkland JM, Acheta J, Marziali LN, Beck B, Jeanette H, Bhatia U, Davis G, Herron J, Roué C, Abi-Ghanem C, Feltri ML, Zuloaga KL, Bechler ME, Poitelon Y, Belin S
Glia 2024 Jan;72(1):156-166
Glia 2024 Jan;72(1):156-166
Activating transcriptional coactivator with PDZ-binding motif by (R)-PFI-2 attenuates osteoclastogenesis and prevents ovariectomized-induced osteoporosis.
Xu R, Liu X, Zhang Y, Wang K, Chen Z, Zheng J, Zhang T, Tong P, Qian Y, Yang W
Biochemical pharmacology 2024 Jan;219:115964
Biochemical pharmacology 2024 Jan;219:115964
Mic19 depletion impairs endoplasmic reticulum-mitochondrial contacts and mitochondrial lipid metabolism and triggers liver disease.
Dong J, Chen L, Ye F, Tang J, Liu B, Lin J, Zhou PH, Lu B, Wu M, Lu JH, He JJ, Engelender S, Meng Q, Song Z, He H
Nature communications 2024 Jan 2;15(1):168
Nature communications 2024 Jan 2;15(1):168
TGFβ and Hippo Signaling Pathways Coordinate to Promote Acinar to Ductal Metaplasia in Human Pancreas.
Nipper M, Xu Y, Liu J, Yin X, Liu Z, Ye Z, Zhang J, Chen Y, Wang P
Cells 2024 Jan 18;13(2)
Cells 2024 Jan 18;13(2)
Transcriptomics analysis revealed that TAZ regulates the proliferation of KIRC cells through mitophagy.
He Z, Shi J, Zhu B, Tian Z, Zhang Z
BMC cancer 2024 Feb 19;24(1):229
BMC cancer 2024 Feb 19;24(1):229
Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial Hypertension.
Hu Y, Zhao C, Tan W, Li M, Wang Y, Gao R, Chen Z, Jin Z, Hu L, Li Q
Journal of medicinal chemistry 2024 Aug 8;67(15):13474-13490
Journal of medicinal chemistry 2024 Aug 8;67(15):13474-13490
DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis.
Xu S, Yuan Z, Jiang C, Chen W, Li Q, Chen T
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Apr;11(16):e2308531
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Apr;11(16):e2308531
LncRNA PVT1 promotes strong stemness and endothelial progenitor cell characteristics in renal carcinoma stem cells.
Wang L, Yang G, Guo P, Lv Y, Fu B, Bai Y, Xiong F, Zhao D, Li C, Zhang J, Bai S, Zeng F, Xu W
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2023 Sep;37(9):e23118
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2023 Sep;37(9):e23118
Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Yuan Y, Xie B, Guo D, Liu C, Jiang G, Lai G, Zhang Y, Hu X, Wu Z, Zheng R, Huang L
Heliyon 2023 Jul;9(7):e18065
Heliyon 2023 Jul;9(7):e18065
Targeting endothelial coagulation signaling ameliorates liver obstructive cholestasis and dysfunctional angiogenesis.
Yang X, Ou Y, Yang Y, Wang L, Zhang Y, Zhao F, Shui P, Qing J
Experimental biology and medicine (Maywood, N.J.) 2023 Jul;248(14):1242-1253
Experimental biology and medicine (Maywood, N.J.) 2023 Jul;248(14):1242-1253
PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling.
Chen H, Yang W, Li Y, Ji Z
Cell death & disease 2023 Jul 15;14(7):433
Cell death & disease 2023 Jul 15;14(7):433
USP15 promotes pulmonary vascular remodeling in pulmonary hypertension in a YAP1/TAZ-dependent manner.
Wu Z, Zhu L, Nie X, Wei L, Qi Y
Experimental & molecular medicine 2023 Jan;55(1):183-195
Experimental & molecular medicine 2023 Jan;55(1):183-195
TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.
Wang YQ, Wu DH, Wei D, Shen JY, Huang ZW, Liang XY, Cho WCS, Ma J, Lv J, Chen YP
Science advances 2023 Jan 6;9(1):eadd0960
Science advances 2023 Jan 6;9(1):eadd0960
Proteomic analysis reveals the aging-related pathways contribute to pulmonary fibrogenesis.
Zhang T, Yuan X, Jiang M, Liu B, Zhai N, Zhang Q, Song X, Lv C, Zhang J, Li H
Aging 2023 Dec 22;15(24):15382-15401
Aging 2023 Dec 22;15(24):15382-15401
Lipid-Sensing Receptor FFAR4 Modulates Pulmonary Epithelial Homeostasis following Immunogenic Exposures Independently of the FFAR4 Ligand Docosahexaenoic Acid (DHA).
Sveiven SN, Anesko K, Morgan J, Nair MG, Nordgren TM
International journal of molecular sciences 2023 Apr 11;24(8)
International journal of molecular sciences 2023 Apr 11;24(8)
The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer.
Wang Y, Nie H, Li H, Liao Z, Yang X, He X, Ma J, Zhou J, Ou C
Frontiers in medicine 2022;9:888093
Frontiers in medicine 2022;9:888093
A positive feedback loop of the TAZ/β-catenin axis promotes Helicobacter pylori-associated gastric carcinogenesis.
Xu X, Shu C, Wu X, Ouyang Y, Cheng H, Zhou Y, Wang H, He C, Xie C, He X, Hong J, Lu N, Ge Z, Zhu Y, Li N
Frontiers in microbiology 2022;13:1065462
Frontiers in microbiology 2022;13:1065462
Mesenchymal Stem Cells Inhibits Migration and Vasculogenic Mimicry in Nasopharyngeal Carcinoma Via Exosomal MiR-125a.
Wan F, Zhang H, Hu J, Chen L, Geng S, Kong L, Lu JJ
Frontiers in oncology 2022;12:781979
Frontiers in oncology 2022;12:781979
Ring finger protein 128 promotes, rather than inhibits, colorectal cancer progression by regulating the Hippo signaling pathway.
Ning S, Chen Y, Wang G, Liu Y, Yang Y, Zhang Z
Frontiers in oncology 2022;12:1031160
Frontiers in oncology 2022;12:1031160
Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and ameliorates organ fibrosis.
Wang L, Zhang Y, Ren Y, Yang X, Ben H, Zhao F, Yang S, Wang L, Qing J
European journal of pharmacology 2022 Oct 15;932:175241
European journal of pharmacology 2022 Oct 15;932:175241
PSMA1 mediates tumor progression and poor prognosis of gastric carcinoma by deubiquitinating and stabilizing TAZ.
Yang Q, Lu Y, Shangguan J, Shu X
Cell death & disease 2022 Nov 23;13(11):989
Cell death & disease 2022 Nov 23;13(11):989
WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells.
Ferrand N, Fert A, Morichon R, Radosevic-Robin N, Zaoui M, Sabbah M
Cancers 2022 Mar 14;14(6)
Cancers 2022 Mar 14;14(6)
The proteasome-dependent degradation of ALKBH5 regulates ECM deposition in PM(2.5) exposure-induced pulmonary fibrosis of mice.
Zhang Y, Liu Q, Ning J, Jiang T, Kang A, Li L, Pang Y, Zhang B, Huang X, Wang Q, Bao L, Niu Y, Zhang R
Journal of hazardous materials 2022 Jun 15;432:128655
Journal of hazardous materials 2022 Jun 15;432:128655
DEPTOR exacerbates bone-fat imbalance in osteoporosis by transcriptionally modulating BMSC differentiation.
Ouyang Z, Kang D, Li K, Liang G, Liu Z, Mai Q, Chen Q, Yao C, Wei R, Tan X, Bai X, Huang B, Li Q
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022 Jul;151:113164
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022 Jul;151:113164
Piezo channels contribute to the regulation of myelination in Schwann cells.
Acheta J, Bhatia U, Haley J, Hong J, Rich K, Close R, Bechler ME, Belin S, Poitelon Y
Glia 2022 Dec;70(12):2276-2289
Glia 2022 Dec;70(12):2276-2289
Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway.
Liu H, Zhang S, Liu Y, Ma J, Chen W, Yin T, Li T, Liang B, Tao L
Respiratory research 2022 Aug 19;23(1):209
Respiratory research 2022 Aug 19;23(1):209
USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ.
Tang J, Luo Y, Xiao L
Cell death & disease 2022 Apr 9;13(4):326
Cell death & disease 2022 Apr 9;13(4):326
Traditional Chinese medicine Yiqi Huoxue recipe attenuates hepatic fibrosis via YAP/TAZ signaling.
Zhao W, Zhang X, Hou M, Zhang Y, Tang Y, Li L, Dong S, Liu L, Zhao D, Li W, Nan Y
Histology and histopathology 2021 Sep;36(9):967-979
Histology and histopathology 2021 Sep;36(9):967-979
YAP drives fate conversion and chemoresistance of small cell lung cancer.
Wu Q, Guo J, Liu Y, Zheng Q, Li X, Wu C, Fang D, Chen X, Ma L, Xu P, Xu X, Liao C, Wu M, Shen L, Song H
Science advances 2021 Oct;7(40):eabg1850
Science advances 2021 Oct;7(40):eabg1850
CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
Nagashima S, Maruyama J, Honda K, Kondoh Y, Osada H, Nawa M, Nakahama KI, Ishigami-Yuasa M, Kagechika H, Sugimura H, Iwasa H, Arimoto-Matsuzaki K, Nishina H, Hata Y
The Journal of biological chemistry 2021 Jul;297(1):100803
The Journal of biological chemistry 2021 Jul;297(1):100803
TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling.
Yang W, Lu X, Zhang T, Han W, Li J, He W, Jia Y, Zhao K, Qin A, Qian Y
Bone research 2021 Jul 12;9(1):33
Bone research 2021 Jul 12;9(1):33
Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty liver disease by regulating the YAP1/TAZ-PPARγ/PGC-1α signaling pathway.
Luo C, Sun H, Peng J, Gao C, Bao L, Ji R, Zhang C, Zhu W, Jin Y
Phytotherapy research : PTR 2021 Feb;35(2):1010-1022
Phytotherapy research : PTR 2021 Feb;35(2):1010-1022
The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ.
Liu T, Yang Y, Xie Z, Luo Q, Yang D, Liu X, Zhao H, Wei Q, Liu Y, Li L, Wang Y, Wang F, Yu J, Xu J, Yu J, Yi P
Molecular therapy. Nucleic acids 2021 Dec 3;26:388-400
Molecular therapy. Nucleic acids 2021 Dec 3;26:388-400
YAP and TAZ regulate Schwann cell proliferation and differentiation during peripheral nerve regeneration.
Jeanette H, Marziali LN, Bhatia U, Hellman A, Herron J, Kopec AM, Feltri ML, Poitelon Y, Belin S
Glia 2021 Apr;69(4):1061-1074
Glia 2021 Apr;69(4):1061-1074
The lncRNA BCYRN1 Functions as an Oncogene in Human Glioma by Downregulating miR-125a-5p in vitro.
Yu W, Xiang D, Jia H, He X, Sheng J, Long Y, Zhu S, Wang K, Liu Q
Cancer management and research 2020;12:1151-1161
Cancer management and research 2020;12:1151-1161
MiR-34a-5p Inhibits Proliferation, Migration, Invasion and Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma by Targeting LEF1 and Inactivation of the Hippo-YAP1/TAZ Signaling Pathway.
Wang X, Zhao Y, Lu Q, Fei X, Lu C, Li C, Chen H
Journal of Cancer 2020;11(10):3072-3081
Journal of Cancer 2020;11(10):3072-3081
YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.
Liu J, Gao M, Xu S, Chen Y, Wu K, Liu H, Wang J, Yang X, Wang J, Liu W, Bao X, Chen J
Cell reports 2020 Sep 8;32(10):108120
Cell reports 2020 Sep 8;32(10):108120
A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
Shreberk-Shaked M, Dassa B, Sinha S, Di Agostino S, Azuri I, Mukherjee S, Aylon Y, Blandino G, Ruppin E, Oren M
Cancer research 2020 Oct 1;80(19):4145-4157
Cancer research 2020 Oct 1;80(19):4145-4157
Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.
Lin BY, Wen JL, Zheng C, Lin LZ, Chen CZ, Qu JM
Journal of cellular and molecular medicine 2020 Nov;24(22):13070-13080
Journal of cellular and molecular medicine 2020 Nov;24(22):13070-13080
Vitamin D3 analogue facilitates epithelial wound healing through promoting epithelial-mesenchymal transition via the Hippo pathway.
Wang D, Lin L, Lei K, Zeng J, Luo J, Yin Y, Li Y, Zhang L, Nie X, Zuo D, Sun L
Journal of dermatological science 2020 Nov;100(2):120-128
Journal of dermatological science 2020 Nov;100(2):120-128
TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.
Zhou S, Liu S, Lin C, Li Y, Ye L, Wu X, Jian Y, Dai Y, Ouyang Y, Zhao L, Liu M, Song L, Xi M
Oncogene 2020 Apr;39(18):3710-3725
Oncogene 2020 Apr;39(18):3710-3725
Jiedu Sangen Decoction Inhibits the Invasion and Metastasis of Colorectal Cancer Cells by Regulating EMT through the Hippo Signaling Pathway.
Yuan L, Zhou M, Wasan HS, Zhang K, Li Z, Guo K, Shen F, Shen M, Ruan S
Evidence-based complementary and alternative medicine : eCAM 2019;2019:1431726
Evidence-based complementary and alternative medicine : eCAM 2019;2019:1431726
miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ.
Yang M, Tang X, Wang Z, Wu X, Tang D, Wang D
Bioscience reports 2019 Dec 20;39(12)
Bioscience reports 2019 Dec 20;39(12)
MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance.
Pan Z, Ding Q, Guo Q, Guo Y, Wu L, Wu L, Tang M, Yu H, Zhou F
International journal of oncology 2018 Jul;53(1):59-72
International journal of oncology 2018 Jul;53(1):59-72
MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer.
Sun W, Lan X, Wang Z, Dong W, He L, Zhang T, Zhang P, Zhang H
Oncology letters 2018 Jan;15(1):1007-1013
Oncology letters 2018 Jan;15(1):1007-1013
Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.
Wu LMN, Deng Y, Wang J, Zhao C, Wang J, Rao R, Xu L, Zhou W, Choi K, Rizvi TA, Remke M, Rubin JB, Johnson RL, Carroll TJ, Stemmer-Rachamimov AO, Wu J, Zheng Y, Xin M, Ratner N, Lu QR
Cancer cell 2018 Feb 12;33(2):292-308.e7
Cancer cell 2018 Feb 12;33(2):292-308.e7
YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells.
Poitelon Y, Lopez-Anido C, Catignas K, Berti C, Palmisano M, Williamson C, Ameroso D, Abiko K, Hwang Y, Gregorieff A, Wrana JL, Asmani M, Zhao R, Sim FJ, Wrabetz L, Svaren J, Feltri ML
Nature neuroscience 2016 Jul;19(7):879-87
Nature neuroscience 2016 Jul;19(7):879-87
Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.
Li L, Fang R, Liu B, Shi H, Wang Y, Zhang W, Zhang X, Ye L
Oncogene 2016 Aug 4;35(31):4048-57
Oncogene 2016 Aug 4;35(31):4048-57
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- MDA-MB-453s cells were subjected to SDS PAGE followed by western blot with 23306-1-AP( WWTR1,TAZ Antibody) at dilution of 1:300
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The TAZ antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human TAZ. This antibody recognizes human antigen. The TAZ antibody has been validated for the following applications: ELISA, WB, IHC analysis.